Real-world data reveals higher reported GLP-1 side effects in female patients
The second of a Series of papers presented at the Annual Meeting of The European Association for the…
Fluorescent sensors could help researchers see diabetes in action
Researchers from the University of Bath have developed fluorescent molecular probes that can detect changes in glucose levels…
Dad says he went permanently blind — in lawsuit against Ozempic makers
Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The…
Exercise may reshape your gut microbiome to support recovery
Researchers reveal how exercise-driven changes in gut microbes could influence recovery and propose a new “intestinal rehabilitation” approach…
Research makes strong case for broader use of GLP1 drugs to protect hearts
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD)…
Why one gut microbe is attracting attention in heart failure research
A multi-omic study links gut bacteria, microbial metabolites, and changes in heart function, pointing to biological relationships that…
Off-Label Use of Ozempic-Style Drugs Is Surging
A large new study suggests weight-loss drugs have quietly moved from medical tool to what one researcher…
WHO to update recommendations on diagnosis of hyperglycaemia in pregnancy
image: ©dragana991 | iStock The World Health Organization (WHO) is preparing to update its recommendations on the screening,…
GLP-1 drugs may influence chronic pain through gut-brain and immune pathways
From microbial metabolites and spinal microglia to osteoarthritis and headache trials, researchers map how GLP-1 signaling intersects with…
Transient ischemic attacks linked to increased long-term dementia risk
Having a transient ischemic attack (TIA) is associated with an increased risk of developing dementia, according to a…
A chemical used in BPA-free products may have a connection to diabetes control
Researchers measured bisphenol exposure alongside diet and medication adherence in adults with type 2 diabetes, uncovering a more…
Ozempic and Wegovy patients sue over alleged NAION vision loss risk
NEWYou can now listen to Fox News articles! Hundreds of consumers are suing the manufacturers of GLP-1 receptor…